A new murine model of pulmonary eosinophilic hypersensitivity: Contribution to experimental asthma

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 3, 1997, Pages 383-388

  De Siqueira, Ana Lúcia Pereira ^a   Russo, Momtchilo ^a   Steil, Ana Angélica ^a   Facincone, Sandra ^a   Mariano, Mario ^a   Jancar, Sonia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Asthma; Eosinophil; Late phase reaction; Mice eosinophil peroxidase

Indexed keywords

PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; EOSINOPHIL; HISTOPATHOLOGY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030868306     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70253-7     Document Type: Article

References (28)

1. H2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
2. Broide DH, Gleich GL, Cuomo AI, Coburn DA, Federman EC, Schwarte LB, et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991,88:637-48.
3. Bousquet J, Chanez P, Lacoste JY, Barnéon G, Ghavamian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
4. Woolley KL, Adelroth E, Wooley R, Ellis R, Jordana M, O'Byrne PM. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic proteins in subjects with and without mild, stable atopic asthma. Eur Respir J 1994;7:1576-84.
5. Nakajima H, Iwamoto I, Yoshida S. Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 1993;148:1102-4.
6. Kips JC, Brusselle GG, Joos GF, Peleman RA, Devos RR, Tavernier JH, et al. Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int Arch Allergy Immunol 1995;107:115-8.
7. DeMonchy JGR, Kauffman HF, Venge P, Köeter GH, Jansen HM, Sluiter HJ, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-6.
8. Pene J, Rousset F, Briere F, Chrétien I, Bonnefoy J-Y, Spits H, et al. IgE production by normal human lymphocytes is induced by interleukin-4 and suppressed by interferons gamma2 and alpha and prostaglandin E2. Froc Natl Acad Sci USA 1988;85:6880-4.
9. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
10. Denburg, Dolovich J, Harnish D. Basophil mast cell and eosinophil growth and differentiation factors in human allergic disease. Clin Exp Allergy 1989;19:249-54.
11. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988;137:62-9.
12. Fergusson AC, Whitelaw MW, Brown H. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma. J Allergy Clin Immunol 1992;90:609-13.
13. Pretolani M, Ruffie C, Joseph D, Campos MG, Church MK, Lefort J, et al. Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am J Respir Crit Care Med 1994;149:1167-74.
14. Frigas E, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest 1980;42:35-43.
15. Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991;87:1470-3.
16. Wardlaw AJ, Knowfes G, Assoufi B, Collins JV, Kay AB. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407-13.
17. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
18. Shaw RJ, Walsh GM, Cromwell O. Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature 1985;316:150-2.
19. Cromwell O, Wardlaw AJ, Champion A, Moqbel R, Osei D, Kay AB, et al. IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. J Immunol 1990;145:3862-8.
20. Barnes PJ, Chung KF, Page C. Inflammatory mediators and asthma. Pharmacol Rev 1988;40:49-84.
21. Pretolani M, Vargaftig BB. From lung hypersensitivity to bronchial hyperreactivity. What we can learn from studies on animal models? Biochem Pharmacol 1993;45:791-800.
22. Facincone S, de Siqueira ALP, Jancar S, Russo M, Barbuto JAM, Mariano M. A novel murine model of late-phase reaction of immediate hypersensitivity. Mediators Inflam 1997;6:127-33.
23. Titus RG, Chiller JM. A simple and effective method to assess murine delayed-type hypersensitivity to proteins. J Immunol Methods 1981;45:65-78.
24. Strath M, Warren DJ, Sanderson CJ. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J Immunol Methods 1985;83:209-15.
25. Martin LB, Kita H, Leiferman KM, Gleich GJ, et al. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol 1996;109:207-15.
26. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131:599-606.
27. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
28. Guéry J-C, Galbiati F, Smiroldo S, Adorini L. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient BALB/c mice. J Exp Med 1996;183:485-97.